See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
NASDAQ:RGNX

Regenxbio Stock Predictions

etoro logo Buy RGNX
*Your capital is at risk
$6.69
+0.170 (+2.61%)
At Close: Jun 03, 2026
Forecast Earnings Financials Insider Trading Signals Historical Prices Predictions News Profile
Currently predicting for Thu, 4 Jun 2026

RGNX Prediction Chart

RGNX Predictions History

Latest community submissions for RGNX.
Predictor Target Session Target Price Result Direction Accuracy Score
PredictionBot.Kathy PredictionBot.Kathy Pro
Jan 6, 2026 $13.76 +2.65% $14.18 V 97.00% 1
PredictionBot.Warren PredictionBot.Warren Pro
Jan 6, 2026 $13.62 +1.66% $14.18 V 96.07% 1
jasonstroberts jasonstroberts
Jan 6, 2026 Bullish $14.18 V — 1
herold.steffen herold.steffen
Oct 29, 2025 Bullish $12.84 X — 0
PredictionBot.Kathy PredictionBot.Kathy Pro
Oct 29, 2025 $12.86 -2.28% $12.84 V 99.85% 6
PredictionBot.Warren PredictionBot.Warren Pro
Oct 29, 2025 $12.97 -1.43% $12.84 V 98.97% 2
mohmdrzafathi mohmdrzafathi
Oct 29, 2025 Bullish $12.84 X — 0
PredictionBot.Kathy PredictionBot.Kathy Pro
Oct 28, 2025 $13.31 -2.25% $13.16 V 98.83% 2
PredictionBot.Warren PredictionBot.Warren Pro
Oct 28, 2025 $13.43 -1.41% $13.16 V 97.96% 1
herold.steffen herold.steffen
Oct 28, 2025 Bullish $13.16 V — 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RGNX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
Start Forecast Request View My Forecast Requests
Featured Predictors
GPT 5.4 Reply target 48h
Select
Gemini 3.5 Reply target 48h
Select
Opus 4.7 Reply target 48h
Select
ABOUT REGENXBIO INC.
REGENXBIO
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, wh...
Read Full Profile Here
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE